Employees: 03 (2023.0)Legal category: Société à responsabilité limitée (sans autre indication)Size: PMECreation date: 2015-03-20 (11 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: SAINT-NAZAIRE (44600), Loire-Atlantique
PHARMACIE RIBAULT : revenue, balance sheet and financial ratios
PHARMACIE RIBAULT is a French company
founded 11 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in SAINT-NAZAIRE (44600),
this company of category PME
shows in 2023 a revenue of 1.7 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE RIBAULT (SIREN 810426601)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
Revenue
N/C
N/C
1 652 764 €
1 622 618 €
N/C
N/C
N/C
N/C
Net income
42 066 €
37 110 €
32 573 €
65 795 €
74 310 €
68 876 €
52 232 €
73 218 €
EBITDA
N/C
N/C
38 553 €
92 699 €
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
2.0%
4.1%
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE RIBAULT generates positive net income of 42 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2018-2025: 73 k€ -> 42 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
42 066 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 45%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 59%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
45.182%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
58.565%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
227.705
158.791
111.613
80.378
59.752
48.461
47.564
45.182
Financial autonomy
26.753
32.983
41.191
48.648
53.342
58.788
55.87
58.565
Repayment capacity
None
None
None
None
3.569
6.095
None
None
Cash flow / Revenue
None%
None%
None%
None%
4.726%
2.211%
None%
None%
Sector positioning
Debt ratio
45.182025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Good+7 pts over 3 years
In 2025, the debt ratio of PHARMACIE RIBAULT (45.18) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
58.56%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Good-6 pts over 3 years
In 2025, the financial autonomy of PHARMACIE RIBAULT (58.6%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
6.09 years2023
2023
Q1: 0.95 years
Med: 3.58 years
Q3: 7.48 years
Average
In 2023, the repayment capacity of PHARMACIE RIBAULT (6.09) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 239.72. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
239.722
Liquidity indicators evolution PHARMACIE RIBAULT
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
279.309
249.482
260.301
294.112
248.007
241.198
214.895
239.722
Interest coverage
None
None
None
None
3.848
6.627
None
None
Sector positioning
Liquidity ratio
239.722025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Good
In 2025, the liquidity ratio of PHARMACIE RIBAULT (239.72) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
6.63x2023
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Excellent
In 2023, the interest coverage of PHARMACIE RIBAULT (6.6x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE RIBAULT
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
0 €
0 €
0 €
0 €
152 039 €
176 333 €
0 €
0 €
Inventory turnover (days)
0
0
0
0
27
29
0
0
Customer payment term (days)
0
0
0
0
6
4
0
0
Supplier payment term (days)
0
0
0
0
22
18
0
0
Positioning of PHARMACIE RIBAULT in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE RIBAULT is estimated at
668 223 €
(range 453 459€ - 1 048 534€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
453k€668k€1048k€
668 223 €Range: 453 459€ - 1 048 534€
NAF 5 année 2025
Valuation method used
Net Income Multiple
42 066 €
×
15.9x
=668 223 €
Range: 453 460€ - 1 048 535€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE RIBAULT with other companies in the same sector:
Frequently asked questions about PHARMACIE RIBAULT
What is the revenue of PHARMACIE RIBAULT ?
The revenue of PHARMACIE RIBAULT in 2023 is 1.7 M€.
Is PHARMACIE RIBAULT profitable?
Yes, PHARMACIE RIBAULT generated a net profit of 42 k€ in 2025.
Where is the headquarters of PHARMACIE RIBAULT ?
The headquarters of PHARMACIE RIBAULT is located in SAINT-NAZAIRE (44600), in the department Loire-Atlantique.
Where to find the tax return of PHARMACIE RIBAULT ?
The tax return of PHARMACIE RIBAULT is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE RIBAULT operate?
PHARMACIE RIBAULT operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart